Steven J. Siegel focuses on Schizophrenia, Neuroscience, Cognition, NMDA receptor and PLGA. His research on Neuroscience frequently links to adjacent areas such as Glutamatergic. His research in Cognition tackles topics such as Audiology which are related to areas like Developmental psychology, Disgust and Anger.
The concepts of his NMDA receptor study are interwoven with issues in Glutamate receptor, Anatomy, Endocrinology and Excitatory postsynaptic potential. His PLGA research includes elements of Polymer, Drug delivery and Dosage form. Many of his research projects under Drug delivery are closely connected to Glycolic acid with Glycolic acid, tying the diverse disciplines of science together.
His primary areas of study are Neuroscience, Schizophrenia, Psychiatry, NMDA receptor and Cognition. The study incorporates disciplines such as Glutamatergic and Autism in addition to Neuroscience. Steven J. Siegel interconnects Psychosis, Internal medicine and Mismatch negativity in the investigation of issues within Schizophrenia.
His NMDA receptor research is multidisciplinary, incorporating perspectives in Glutamate receptor, Endocrinology, Parvalbumin and Ketamine. His Cognition research incorporates elements of Cognitive psychology and Audiology. His Electrophysiology study deals with Gating intersecting with Sensory system, Nicotine and Evoked potential.
His primary scientific interests are in Neuroscience, NMDA receptor, Schizophrenia, Fragile X syndrome and Cognition. Steven J. Siegel works on Neuroscience which deals in particular with Amygdala. His biological study spans a wide range of topics, including Glutamate receptor, Signal transduction and Parvalbumin.
In his work, Clinical psychology and Quality of life is strongly intertwined with Psychiatry, which is a subfield of Glutamate receptor. Steven J. Siegel has included themes like Open field, Autism, Spontaneous alternation, PI3K/AKT/mTOR pathway and Long-term depression in his Fragile X syndrome study. His work carried out in the field of Cognition brings together such families of science as Nicotine and Electroencephalography.
His primary areas of investigation include Neuroscience, Fragile X syndrome, Schizophrenia, Autism and Mismatch negativity. The Local circuit research Steven J. Siegel does as part of his general Neuroscience study is frequently linked to other disciplines of science, such as Homogeneous, therefore creating a link between diverse domains of science. His Fragile X syndrome research is multidisciplinary, incorporating elements of Long-term memory, Executive dysfunction, Hippocampus, PI3K/AKT/mTOR pathway and Long-term depression.
His Schizophrenia study incorporates themes from Cognition and Electroencephalography. Steven J. Siegel has researched Autism in several fields, including Psychopharmacology, Dopamine receptor and Medium spiny neuron, Striatum. His work in Mismatch negativity covers topics such as Sensory system which are related to areas like Audiology and Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia;Steven J. Siegel.
Facial Emotion Recognition in Schizophrenia: Intensity Effects and Error Pattern
Christian G. Kohler;Travis H. Turner;Warren B. Bilker;Colleen M. Brensinger.
American Journal of Psychiatry (2003)
Altered neuregulin 1¿erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia
Chang-Gyu Hahn;Hoau-Yan Wang;Dan-Sung Cho;Konrad Talbot.
Nature Medicine (2006)
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia
Konrad Talbot;Wess L. Eidem;Caroline L. Tinsley;Matthew A. Benson.
Journal of Clinical Investigation (2004)
Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
Avinash Budhian;Steven J. Siegel;Karen I. Winey.
International Journal of Pharmaceutics (2007)
Computerized neurocognitive scanning: I. Methodology and validation in healthy people.
Ruben C Gur;J Daniel Ragland;Paul J Moberg;Travis H Turner.
Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus.
S. J. Siegel;N. Brose;W. G. Janssen;G. P. Gasic.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Validating γ oscillations and delayed auditory responses as translational biomarkers of autism.
Michael J. Gandal;J. Christopher Edgar;Richard S. Ehrlichman;Mili Mehta.
Biological Psychiatry (2010)
Self-face recognition and theory of mind in patients with schizophrenia and first-degree relatives
Farzin Irani;Steven M. Platek;Ivan S. Panyavin;Monica E. Calkins.
Schizophrenia Research (2006)
Flat Affect in Schizophrenia: Relation to Emotion Processing and Neurocognitive Measures
Raquel E Gur;Christian G Kohler;J Daniel Ragland;Steven J Siegel.
Schizophrenia Bulletin (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: